PD Dr. Arnd Kleyer



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

PREVALENCE AND CHARACTERISTICS OF SPONDYLOARTHRITIS ACCORDING TO ASAS CRITERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - RESULTS FROM THE SPICE COHORT (2017) Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Zimmermann J, Faustini F, Simon D, et al. Conference contribution Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain - an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial (2017) Schenker H, Heß A, Konerth L, Sergeeva M, Prade J, Kleyer A, Reiser M, et al. Conference contribution Innate Lymphoid Cells - New Players in Psoriatic Arthritis (2017) Soare A, Weber S, Maul L, Gheorghiu AM, Housni I, Kleyer A, Luber M, et al. Conference contribution Increased Cartilage Damage in Metacarpophalangeal Joints of ACPA Positive Rheumatoid Arthritis (RA) Patients Using T2 Mapping in 3 Tesla Magnetresonance Imaging (MRI) (2017) Renner N, Kleyer A, Simon D, Krönke G, Rech J, Schett G, Welsch G, Pachowsky M Conference contribution INCREASE OF CORTICAL MICRO-CHANNELS (COMICS) AS A NEW FEATURE OF STRUCTURAL DAMAGE IN PAIENTS WITH RHEUMATOID ARTHRITIS (2017) Werner D, Simon D, Englbrecht M, Stemmler F, Berlin A, Haschka J, Renner N, et al. Conference contribution Th2 and eosinophil responses ameliorate arthritis and inflammatory bone loss (2017) Andreev D, Chen Z, Oeser K, Krljanac B, Hueber A, Kleyer A, Weigmann B, et al. Conference contribution MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION (2017) Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, et al. Conference contribution QUANTIFICATION AND IMPACT OF SECONDARY OSTEOARTHRITIS USING HR-PQCT IN ANTI-CITRULLINATED PROTEIN ANTIBODY RHEUMATOID ARTHRITIS PATIENTS (2017) Figueiredo C, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, et al. Conference contribution Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs (2017) Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber A, Haschka J, Manger B, et al. Journal article Hard palate hyperpigmentation - a rare side effect of antimalarials (2017) Manger K, von Streitberg U, Seitz G, Kleyer A, Manger B Journal article